Search results

Journal Article (86)

  1. Journal Article
    Konrad, M.: Molecular analyses of adenylate kinases and guanylate kinases from yeasts. Biological Chemistry Hoppe-Seyler 372 (9), pp. 695 - 696 (1991)
  2. Journal Article
    Vetter, I. R.; Reinstein, J.; Konrad, M.; Goody, R. S.; Rosch, P.: NMR-studies of the nuleotide binding-sites of adenylate kinase. Biological Chemistry Hoppe-Seyler 372 (9), p. 772 - 772 (1991)
  3. Journal Article
    Vetter, I. R.; Konrad, M.; Rosch, P.: Complexes of yeast adenylate kinase and nucleotides investigated by 1H NMR. Biochemistry 30 (17), pp. 4137 - 4142 (1991)
  4. Journal Article
    Konrad, M.: Plasmid DNA sequencing using highly degenerate oligonucleotides as primers. Nucleic Acids Research 18 (17), p. 5320 - 5320 (1990)
  5. Journal Article
    Konrad, M.: Analysis and in vivo disruption of the gene coding for adenylate kinase (ADK1) in the yeast Saccharomyces cerevisiae. Journal of Biological Chemsitry 263 (36), pp. 19468 - 19474 (1988)
  6. Journal Article
    Konrad, M.: Analysis and in vivo disruption of the gene coding for adenylate kinase (ADK1) in the yeast Saccharomyces cerevisiae. Journal of Biological Chemistry 263, pp. 19468 - 19474 (1988)

Conference Paper (11)

  1. Conference Paper
    Konrad, M.: Molecular engineering of L-asparaginases used in antileukemic therapy. 40th Congress of the Federation of European Biochemical Societies (FEBS) - The Biochemical Basis of Life, Berlin, July 04, 2015 - July 09, 2015. FEBS Journal (2015)
  2. Conference Paper
    Karamitros, C. S.; Konrad, M.: L-asparaginases as therapeutic enzymes for the treatment of leukemia. 9th International Conference of Anticancer Research, Sithonia, Greece, October 06, 2014 - October 10, 2014. Anticancer Research 34, p. 6004 - 6004 (2014)
  3. Conference Paper
    Konrad, M.; Karamitros, C. S.: Molecular engineering of L-asparaginases as therapeutic enzymes for the treatment of leukemia. 28th Annual Symposium of the Protein-Society, San Diego, CA, July 27, 2014 - July 30, 2014. Protein Science 23 (Supplement 1), pp. 79 - 80 (2014)
  4. Conference Paper
    Konrad, M.; Karamitros, C. S.; Lavie, A.: Therapeutic enzymes for the treatment of leukemia: Autoproteolytic activation of human asparaginase induced by free glycine. 38th Congress of the Federation-of-European-Biochemical-Societies (FEBS) , Saint Petersburg, RUSSIA, July 06, 2013 - July 11, 2013. FEBS Journal 280 (Supplement 1), pp. 326 - 327 (2013)
  5. Conference Paper
    Konrad, M.; Lavie, A.; Paarmann, I.: Calcium-dependent interaction of calmodulin with synapse-associated proteins of the MAGUK family. FEBS Journal 274 (Suppl. 1), p. 146 - 146 (2007)
  6. Conference Paper
    Konrad, M.; McSorley, T.; Lavie, A.: Molecular engenieering and intracellular delivery of nucleoside kinases to improve anticancer and antiviral therapy. FEBS Journal 274 (Suppl. 1), p. 238 - 238 (2007)
  7. Conference Paper
    Konrad, M.; Ort, S.; Monnerjahn, C.; Lavie, A.: Engineering of nucleoside kinases to improve the activation of nucleoside analog prodrugs. FEBS Journal 273 (Suppl. 1), p. 50 - 50 (2006)
  8. Conference Paper
    Sato, T.; Neschadim, A.; Rasaiah, V.; Konrad, M.; Lavie, A.; Medin, J. A.: Development of a novel lentivirus-based suicide gene therapy approach using modified human thymidylate monophosphate kinase. Journal of Gene Medicine 8 (3), p. 399 - 399 (2006)
  9. Conference Paper
    Sato, T.; Neschadim, A.; Rasaiah, V.; Konrad, M.; Fowler, D. H.; Lavie, A.; Medin, J. A.: A novel suicide gene therapy approach for reduction of GvHD using lentiviral delivery of a modified human thymidylate monophosphate kinase. Blood 106 (11), p. 397B - 397B (2005)
  10. Conference Paper
    Heimburg, T.; Hac, A. E.; Pollakowski, D.; Konrad, M.: Bacterial motility measured by fluorescence correlation spectroscopy, and its relationship to heat capacity anomalies in the membrane. Biophysical Journal 88 (1), p. 526A - 526A (2005)
  11. Conference Paper
    Sekulic, N.; Shuvalova, L.; Spangenberg, O.; Konrad, M.; Lavie, A.: Structural characterization of the closed conformation of mouse guanylate kinase. Protein Science 13 (Suppl. 1), pp. 190 - 191 (2004)

Meeting Abstract (1)

  1. Meeting Abstract
    Konrad, M.; Gruber, J.; McSorley, T.; Too, W. C. S.: Balance of human choline kinase isoform expression is critical for cell cycle regulation: Implications for the development of choline kinase-targeted cancer therapy. In FEBS Journal, 279 (Supplement 1), p. 103 - 103. 22nd IUBMB Congress/37th FEBS Congress, Seville/Spain, September 04, 2012 - September 09, 2012. (2012)
Go to Editor View